Jinalben Patel on Muck Rack

Jinalben Patel

As seen in: Wiley Online Library
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Jinalben

Contact Jinalben, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

CD19 Directed CAR T Therapy for Transformed Follicular Lymphoma: A CIBMTR Analysis

|
By Swetha Kambhampati Thiruvengadam, Kwang Woo Ahn, Jinalben Patel, Qinghua Lian
| Wiley Online Library Verified
Conflicts of Interest Swetha Kambhampati Thiruvengadam—Advisory Board: Kite Pharma, Abbvie, Tazemetostat; Research Funding: Genmab, Abbvie, Genentech, ADC-Therapeutics, Ipsen. Leland Metheny—Pfizer-research, Incyte-speakers bureau, Taiho-speakers bureau.
Open in Who Shared Issue with article?

Chimeric antigen receptor T‐cell therapy for high‐grade B‐cell lymphoma NOS

|
By Nasheed M. Hossain, Kwang Woo Ahn, Jinalben Patel, Qinghua Lian
| Wiley Online Library Verified
CONFLICT OF INTEREST STATEMENT Mehdi Hamadani reports research support/Funding: ADC Therapeutics; Spectrum Pharmaceuticals; Astellas Pharma. Consultancy: ADC Therapeutics, Omeros, CRISPR, BMS, Kite, AbbVie, Caribou, Genmab, Autolus, Forte Biosciences, Byondis, Allovir, Poseidon. Speaker's Bureau: ADC Therapeutics, AstraZeneca, Bei Gene, Kite, Sobi. DMC: Inc., Genentech, Myeloid Therapeutics, CRISPR. David Rizzieri: None. Muhammad Husnain: Consultancy Kite Pharma. R.
Open in Who Shared Issue with article?

Autologous Transplant or CAR‐T as Consolidation Options in MYC Rearranged Large B‐Cell Lymphoma Patients in Remission After Salvage Treatments

|
By Fateeha Furqan, Kwang W. Ahn, Manmeet Kaur, Jinalben Patel
| Wiley Online Library Verified
6 Conflicts of Interest Farrukh T. Awan reports consultancy: Loxo Oncology, Beigene, Dava Oncology, Astrazeneca, Genmab, Adaptive Biotechnologies, BMS, Abbvie, Incyte, Kite pharma, Caribou Biosciences, ADCT therapeutics, and received research funding from Abbvie/Pharmacyclics. Evandro Bezerra reports advisory board: Novartis, Kite, Kyverna.
Open in Who Shared Issue with article?
See all 3 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified